
FDA, Patients, and Providers: A Brand New “Relation-shift.”
I’m very positive about the future role of the FDA in ensuring that stem cell and related therapies are safe and effective. And, because of that, I believe now is the appointed time for both patients and therapy providers to be intentional in helping to rewire their own perspectives and consider what it might be like to work with the FDA. In a few days, I’ll have the pleasure of meeting with Dr. Peter Marks, MD and Ph.D., Director of the Center for Biologics Evaluation and Re